| Effect | None |
| Trial Design | Double blind |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 23 |
| Sex | Female |
| Age Range | 18-29, 30-44, 45-64 |
| Body Types | Overweight, Average |
Supplementation of 40mg Promensil twice daily over the course of one month was able to slightly increase HDL-C concentrations () while there was no influence on IGF or any of its binding proteins, although when excluding postmenopausal women from the analysis there was a trend to reduce IGF-1 only.
